At a glance
Dupont De Nemours Inc is worth $19.08B. Revenue grew 1.9% to $6.85B in fiscal 2025, at a loss. It pays a 2.69% dividend yield, and returned $5.31B to shareholders in dividends and buybacks over FY2021–FY2025. The stock returned +41.6% over the past year with dividends reinvested and −7.2% a year over five years, against +11.5% and +11.7% for the S&P 500. At its worst it fell 46.4% in the 2020 crash (S&P 500: 33.7%) and 40.2% in the 2022 bear market (S&P 500: 24.5%), and was back at its earlier high 2 months and 20 months after the lows.
The business in plain English
DuPont de Nemours makes specialty materials and engineered products and sells them to other businesses, often under its own brands. Customers include medical device and biopharma companies, operators of industrial and city water systems, builders, and makers of cars, aircraft and packaging. It has subsidiaries in about 50 countries and factories in about 20.
Since the fourth quarter of 2025, DuPont has reported two segments. Diversified Industrials made up 52.8% of 2025 revenue of $6.85 billion. It sells building products such as TYVEK house wrap, STYROFOAM insulation and CORIAN solid surfaces. It also sells MOLYKOTE lubricants, BETASEAL adhesives and Cyrel printing plates. Healthcare & Water Technologies made up 47.2%. It sells TYVEK medical packaging, medical device components and TYCHEM protective suits. It also sells FILMTEC reverse osmosis filters and AMBERLITE resins that purify water. The United States accounted for 46.5% of sales, Asia Pacific 23.9% and Europe, the Middle East and Africa 21.4%.
The company began as DowDuPont and has since shrunk by splitting off businesses. It spun off Dow and Corteva in 2019 and combined its nutrition business with IFF in 2021. On November 1, 2025, it spun off its electronics arm as Qnity Electronics, handing DuPont shareholders Qnity stock. Its annual report filed February 17, 2026 said a sale of the Aramids business to Arclin was expected to close around the end of the first quarter of 2026.
Price history
The interactive chart needs JavaScript.
DD +41.6% over the year to Nov 2, 2026, total return with dividends reinvested.
How it makes money
By business segment
| Diversified Industrials | $3.62B | 52.8% |
| Healthcare & Water Technologies | $3.23B | 47.2% |
By geography
| United States | $3.19B | 46.5% |
| Asia Pacific | $1.64B | 23.9% |
| EMEA | $1.47B | 21.4% |
| Latin America | $326.0M | 4.8% |
| Canada | $227.0M | 3.3% |
Latest results
- In Q2 FY2026 (ended Jun 30, 2026), revenue was $1.82B, up 4% from a year earlier, and net income was $143.0M (+142.4%).
- For fiscal 2025, revenue was $6.85B (+1.9% year over year) with a -11.4% net margin.
Financial health check
| Free cash flow margin | 3.3% watch |
|---|---|
| Return on equity (FY2025) | -5.6% weak |
| Return on assets (FY2025) | -3.6% weak |
| Net cash (cash minus debt) | $-1.39B watch |
| Fiscal year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| FY2020 | $11.13B | $-2.95B | $2.90B |
| FY2021 | $12.57B | $6.47B | $1.49B |
| FY2022 | $13.02B | $5.87B | $-74.0M |
| FY2023 | $6.61B | $423.0M | $543.0M |
| FY2024 | $6.72B | $703.0M | $480.0M |
| FY2025 | $6.85B | $-779.0M | $227.0M |
Valuation snapshot
| Market value | $19.08B |
|---|---|
| P/E ratio | — |
| Dividend yield | 2.69% |
Rank among 1514 US companies
Market value at each year end
Dupont De Nemours’s market value went from $47.61B at the end of 2019 to $19.08B on Nov 2, 2026, down 60%; since the end of 2025 it is up 13%.
Show as a table
| Year end | Market value | Change |
|---|---|---|
| Nov 2, 2026 | $19.08B | +13.2% |
| 2025 | $16.86B | -47.2% |
| 2024 | $31.90B | -3.7% |
| 2023 | $33.12B | -3.0% |
| 2022 | $34.13B | -18.5% |
| 2021 | $41.89B | -19.8% |
| 2020 | $52.24B | +9.7% |
| 2019 | $47.61B |
Price behavior
| YTD | 1 yr | 3 yr | 5 yr | 10 yr | |
|---|---|---|---|---|---|
| DD price data to Nov 2, 2026 | +19.7% | +41.6% | -9.0% | -7.2% | — |
Show as a table
| Year | Price data |
|---|---|
| 2026 (to date) | +19.7% |
| 2025 | -45.3% |
| 2024 | +1.5% |
| 2023 | +14.3% |
| 2022 | -13.4% |
| 2021 | +15.4% |
| 2020 | +13.3% |
| 2008 financial crisis stocks fell Oct 9, 2007 – Mar 9, 2009 | Before this security existed |
|---|---|
| 2020 COVID crash stocks fell Feb 19, 2020 – Mar 23, 2020 | Lost 46.4% over that stretch · deepest drop along the way 46.4%, back to its old high 2.4 months after the low |
| 2022 bear market stocks fell Jan 3, 2022 – Oct 12, 2022 | Lost 35.1% over that stretch · deepest drop along the way 40.2%, back to its old high 20 months after the low |
Insider activity
Form 4 filings from 2025-10-27 to 2026-10-27 (25 read): 0 open-market purchases and 1 sales ($13K).
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 2, 2026 | Lori Koch CEO, Director | sell | $13K |
Who owns it
Large shareholders (13G filings)
| Vanguard Capital Management | 7.51% | Mar 31, 2026 |
| STATE STREET CORPORATION | 5.1% | Jun 30, 2026 |
ETFs with the most weight in DD
| XLB Materials Select Sector SPDR Fund | 3.59% |
| RSPM Invesco S&P 500 Equal Weight Materials ETF | 3.26% |
| VAW Vanguard Materials ETF | 2.52% |
| BRIF FIS Bright Portfolios Focused Equity ETF | 2.46% |
| FMAT Fidelity MSCI Materials Index ETF | 2.04% |
| CZA Invesco Zacks Mid-Cap ETF | 1.71% |
| ABEQ Absolute Select Value ETF | 1.53% |
| WDNA WisdomTree BioRevolution Fund | 1.34% |
What could go wrong
- IRS could challenge Qnity spin-off's tax-free status. Qnity's November 1, 2025 spin-off was set up to be tax-free, backed by a legal opinion. If the IRS disagrees, DuPont could owe significant taxes, though Qnity may share some of them.
- PFAS lawsuits and shared cost commitments. Under a January 22, 2021 agreement, DuPont shares future eligible costs from PFAS, which are long-lasting man-made chemicals, with Corteva, EIDP and Chemours. Lawsuits and related commitments could hurt results.
- Leftover tax exposure from past breakups. DuPont may still owe some taxes tied to Dow and Corteva after their 2019 spin-offs. The 2021 combination of its nutrition business with IFF could also lead to a significant tax bill.
- Aramids sale timing and outcome uncertain. The annual report filed February 17, 2026 expected the Aramids sale to Arclin to close around the end of the first quarter of 2026, pending regulatory approvals. Its timing and outcome carry risk.
- Frequent deals bring execution and write-down risk. DuPont has sold or spun off several businesses and bought others, such as Spectrum, Donatelle and Sinochem. Poorly run deals could hurt results, and so could a write-down of goodwill (the premium paid for acquisitions).
- Most sales come from outside the US. The United States made up 46.5% of 2025 sales, so most revenue comes from abroad. Currency swings, geopolitics, trade disputes and probes by foreign governments can cut sales or make products less competitive.
Recent events
- Major agreement signed; Investor presentation or announcement
- Quarterly results released
- Change to shareholder rights; Bylaws or fiscal year changed
- Shareholder vote results; Investor presentation or announcement
- Quarterly results released
- Executive or board change
- Other company announcement
- Investor presentation or announcement
- Quarterly results released
- Executive or board change
For income and retirement investors
DuPont pays a dividend, yielding 2.74% as of October 28, 2026, but has no streak of increases. The figures here are adjusted for a 1-for-3 reverse stock split around August 2026, which combined every three shares into one. Dividends per share rose from $3.60 in 2020 to $4.56 in 2024, then fell to $4.29 in 2025. Neither earnings nor free cash flow covered the 2025 payout. DuPont posted a $779 million net loss, and dividends paid of $597 million were about 263% of free cash flow (cash left after capital spending). Buybacks totaled $2.1 billion over 2021–2025, and the share count fell 22.5% from August 2021 to July 2026.
In the 2020 COVID crash the stock dropped 46.4% but got back to its earlier high in about 2.4 months. In the 2022 market slump it fell 40.2% and took about 20 months to recover. Its price history does not go back to 2008. A single stock carries more risk than a diversified fund spread across many companies.
Questions investors ask
How does DuPont make money?
DuPont makes money by selling specialty materials and engineered products to other businesses. Revenue was $6.85 billion in 2025. Diversified Industrials made up 52.8%. It sells building products such as TYVEK house wrap and STYROFOAM insulation, plus industrial lubricants, adhesives and printing plates. Healthcare & Water Technologies made up 47.2%. It sells medical packaging, medical device parts and water purification products such as FILMTEC filters. The United States accounted for 46.5% of sales.
Does DuPont raise its dividend every year?
No. DuPont's dividend per share fell from $4.56 in 2024 to $4.29 in 2025, so it has no run of yearly increases. These figures are adjusted for a 1-for-3 reverse stock split around August 2026. From 2020 to 2025, regular dividends per share grew about 3.6% a year on average. In 2025 the company posted a $779 million net loss. The $597 million it paid in dividends was about 263% of free cash flow. The yield was 2.74% as of October 28, 2026.
What is Qnity and how is it related to DuPont?
Qnity Electronics is DuPont's former semiconductor and interconnect solutions business. DuPont spun it off as a separate public company on November 1, 2025. All of Qnity's shares went to people who owned DuPont stock on October 22, 2025, and Qnity made a cash payment to DuPont beforehand. DuPont then regrouped into two segments. One risk remains: if the IRS (the US tax agency) rules that the spin-off was not tax-free, DuPont could owe significant taxes, though Qnity may share some of them.
Does DuPont still face PFAS “forever chemical” costs?
Yes. Under a memorandum of understanding signed January 22, 2021, DuPont, Corteva, EIDP and Chemours agreed to share future eligible costs related to PFAS. These are long-lasting man-made chemicals often called “forever chemicals.” DuPont's annual report lists this as a risk factor. It warns that lawsuits and other commitments could hurt its results, including how the cost-sharing arrangement plays out.
How much debt does DuPont have?
DuPont had $3.1 billion of total debt and $1.7 billion of cash and investments as of June 30, 2026. That left net debt (debt minus cash) of about $1.4 billion. On the same date, shareholders' equity was $13.8 billion and total assets were $21.1 billion. DuPont's annual report warns that a change in its credit ratings could raise its borrowing costs or limit its access to debt markets.